ChromaDex (CDXC) Misses Q3 EPS by 3c

ChromaDex (NASDAQ: CDXC) reported Q3 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.1 million versus the consensus estimate of $8.37 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• Sharon AI surges premarket; New Oriental gains, Medline slips